The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis

Conclusions:
DMDs appear to attenuate brain atrophy over time in patients with CIS. The effect of DMDs on brain-volume loss is evident after the first year of treatment.

Source: Therapeutic Advances in Neurological Disorders - October 7, 2015 Category: Neurology Authors: Tsivgoulis, G., Katsanos, A. H., Grigoriadis, N., Hadjigeorgiou, G. M., Heliopoulos, I., Papathanasopoulos, P., Dardiotis, E., Kilidireas, C., Voumvourakis, K., on behalf of HELANI (Hellenic Academy of Neuroimmunology) Tags: Original Research Source Type: research